Radiation therapy for early-stage voice box cancer with poor differentiation
Part of Cancer, Ear, nose & throat clinical trials.
This trial studies whether adding radiation therapy after surgery can help people with early-stage voice box cancer that has poor differentiation (cells look very abnormal). It aims to improve outcomes for this specific type of cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with squamous cell carcinoma of the voice box (glottic laryngeal cancer).
- Your cancer is early-stage (T1 or T2) and has not spread to lymph nodes or other parts of the body (N0M0).
- Your cancer is considered poorly differentiated (cells look very abnormal under a microscope).
- You had surgery to remove the cancer 4 to 8 weeks ago, with the goal of curing it.
- You have not had chemotherapy, radiation, or other cancer treatments before.
- You are in good general health (able to care for yourself, ECOG score 0 or 1).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether adding radiation therapy after surgery improves outcomes for people with early-stage glottic cancer that involves the anterior commissure (the front part of the vocal cords). If you join, you may receive radiation therapy or not, and the researchers will compare the results.
This trial tests treatment approaches for people with cancers of the voice box (larynx) or lower throat (hypopharynx). It may help by finding which treatment strategy works best for different tumor locations and cancer stages.
This trial tests a shorter course of radiation therapy for early-stage vocal cord cancer. The aim is to see if giving slightly higher doses per session (3.5 Gy) is safe and effective.
This trial tests whether giving radiation after surgery can lower the risk of the cancer coming back for people with oral tongue cancer that has specific high-risk features but not advanced spread. It aims to find the best treatment plan for patients with certain tumor characteristics.
This study compares two standard treatments for early-stage cancer in the upper part of the voice box (supraglottic larynx) that hasn't spread to neck lymph nodes: radiation therapy versus surgical removal of the neck lymph nodes. The goal is to see which approach better controls the cancer while preserving quality of life.
This study compares ways of treating early squamous cell cancer in the tonsil or the tongue base, using either radiation therapy, transoral (through-the-mouth) surgery, or both. It aims to see which approach works best while keeping cancer under control.
Hear when a new Early Stage Glottic Squamous Cell Carcinoma With Poor Differentiation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.